Stockholders’ Equity (Details Narrative) - USD ($) |
6 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Proceeds from sale of common stock | $ 10,178,627 | |
Proceeds from the exercise of warrants | $ 2 | |
Series B Warrant [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Warrants exercised | 23,863 | |
Proceeds from the exercise of warrants | $ 2 | |
Net share settled | 2,242,427 | |
Sale of common stock, net of issuance costs, shares | 2,242,339 | |
Chanticleer Warrants [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Sale of common stock, net of issuance costs, shares | 185,422 | |
Number of purchase warrant | 186,161 | |
Warrant exercise price | $ 0.01 | |
At The Market Sales Agreement [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Sale of stock, shares | 4,021,561 | |
Gross proceeds from sale agreement | $ 10,600,000 | |
Proceeds from sale of common stock | $ 10,200,000 |
X | ||||||||||
- Definition Net share settled. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|